BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30930219)

  • 1. NMR structure of CmPI-II, a non-classical Kazal protease inhibitor: Understanding its conformational dynamics and subtilisin A inhibition.
    Cabrera-Muñoz A; Valiente PA; Rojas L; Alonso-Del-Rivero Antigua M; Pires JR
    J Struct Biol; 2019 Jun; 206(3):280-294. PubMed ID: 30930219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H, 13C and 15N resonance assignments and secondary structure analysis of CmPI-II, a serine protease inhibitor isolated from marine snail Cenchritis muricatus.
    Cabrera-Muñoz A; Rojas L; Alonso-del-Rivero Antigua M; Pires JR
    Biomol NMR Assign; 2016 Apr; 10(1):153-6. PubMed ID: 26547437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and comparative 3D modeling of CmPI-II, a novel 'non-classical' Kazal-type inhibitor from the marine snail Cenchritis muricatus (Mollusca).
    González Y; Pons T; Gil J; Besada V; Alonso-del-Rivero M; Tanaka AS; Araujo MS; Chávez MA
    Biol Chem; 2007 Nov; 388(11):1183-94. PubMed ID: 17976011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine substitution by alanine at the P1 position increases the selectivity of CmPI-II, a non-classical Kazal inhibitor.
    Rojas L; Cabrera-Muñoz A; Gil Pradas D; González JB; Alonso-Del-Rivero M; González-González Y
    Biochem Biophys Rep; 2021 Jul; 26():101008. PubMed ID: 34027134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterologous expression of Cenchritis muricatus protease inhibitor II (CmPI-II) in Pichia pastoris system: Purification, isotopic labeling and preliminary characterization.
    Cabrera-Muñoz A; Rojas L; Gil DF; González-González Y; Mansur M; Camejo A; Pires JR; Alonso-Del-Rivero Antigua M
    Protein Expr Purif; 2016 Oct; 126():127-136. PubMed ID: 27353494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and partial characterization of human neutrophil elastase inhibitors from the marine snail Cenchritis muricatus (Mollusca).
    González Y; Tanaka AS; Hirata IY; del Rivero MA; Oliva ML; Araujo MS; Chávez MA
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Apr; 146(4):506-13. PubMed ID: 16546427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changing the inhibitory specificity and function of the proteinase inhibitor eglin c by site-directed mutagenesis: functional and structural investigation.
    Heinz DW; Hyberts SG; Peng JW; Priestle JP; Wagner G; Grütter MG
    Biochemistry; 1992 Sep; 31(37):8755-66. PubMed ID: 1390662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The covalent structure of the elastase inhibitor from Anemonia sulcata--a "non-classical" Kazal-type protein.
    Tschesche H; Kolkenbrock H; Bode W
    Biol Chem Hoppe Seyler; 1987 Oct; 368(10):1297-304. PubMed ID: 2892502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Refined crystal structures of subtilisin novo in complex with wild-type and two mutant eglins. Comparison with other serine proteinase inhibitor complexes.
    Heinz DW; Priestle JP; Rahuel J; Wilson KS; Grütter MG
    J Mol Biol; 1991 Jan; 217(2):353-71. PubMed ID: 1992167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for dual-inhibition mechanism of a non-classical Kazal-type serine protease inhibitor from horseshoe crab in complex with subtilisin.
    Shenoy RT; Thangamani S; Velazquez-Campoy A; Ho B; Ding JL; Sivaraman J
    PLoS One; 2011 Apr; 6(4):e18838. PubMed ID: 21541315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory specificity change of the ovomucoid third domain of the silver pheasant upon introduction of an engineered Cys14-Cys39 bond.
    Hemmi H; Kumazaki T; Yamazaki T; Kojima S; Yoshida T; Kyogoku Y; Katsu M; Shinohara F; Yokosawa H; Miura K; Kobayashi Y
    Biochemistry; 2003 Mar; 42(9):2524-34. PubMed ID: 12614146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Kazal-type inhibitor domains with serine proteinases: biochemical and structural studies.
    Schlott B; Wöhnert J; Icke C; Hartmann M; Ramachandran R; Gührs KH; Glusa E; Flemming J; Görlach M; Grosse F; Ohlenschläger O
    J Mol Biol; 2002 Apr; 318(2):533-46. PubMed ID: 12051857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional study of an Anemonia elastase inhibitor, a "nonclassical" Kazal-type inhibitor from Anemonia sulcata.
    Hemmi H; Kumazaki T; Yoshizawa-Kumagaye K; Nishiuchi Y; Yoshida T; Ohkubo T; Kobayashi Y
    Biochemistry; 2005 Jul; 44(28):9626-36. PubMed ID: 16008348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirement for a disulfide bridge near the reactive site of protease inhibitor SSI (Streptomyces subtilisin inhibitor) for its inhibitory action.
    Kojima S; Kumagai I; Miura K
    J Mol Biol; 1993 Mar; 230(2):395-9. PubMed ID: 8464055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel double-headed proteinaceous inhibitor for metalloproteinase and serine proteinase.
    Hiraga K; Suzuki T; Oda K
    J Biol Chem; 2000 Aug; 275(33):25173-9. PubMed ID: 10827083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and function analysis of a Kazal-type serine proteinase inhibitor in the red claw crayfish Cherax quadricarinatus.
    Wang Y; Wang B; Liu M; Jiang K; Wang M; Wang L
    Dev Comp Immunol; 2021 Jan; 114():103871. PubMed ID: 32946920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two disulfide bridge Kazal domain from Phytophthora exhibits stable inhibitory activity against serine proteases of the subtilisin family.
    Tian M; Kamoun S
    BMC Biochem; 2005 Aug; 6():15. PubMed ID: 16117831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structure of Aedes aegypti trypsin inhibitor in complex with μ-plasmin reveals role for scaffold stability in Kazal-type serine protease inhibitor.
    Walvekar VA; Ramesh K; Jobichen C; Kannan M; Sivaraman J; Kini RM; Mok YK
    Protein Sci; 2022 Feb; 31(2):470-484. PubMed ID: 34800067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homologous proteins with different folds: the three-dimensional structures of domains 1 and 6 of the multiple Kazal-type inhibitor LEKTI.
    Lauber T; Schulz A; Schweimer K; Adermann K; Marx UC
    J Mol Biol; 2003 Apr; 328(1):205-19. PubMed ID: 12684009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial activity of a honeybee (Apis cerana) venom Kazal-type serine protease inhibitor.
    Kim BY; Lee KS; Zou FM; Wan H; Choi YS; Yoon HJ; Kwon HW; Je YH; Jin BR
    Toxicon; 2013 Dec; 76():110-7. PubMed ID: 24076031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.